sur HBM Healthcare Investments AG (ETR:CH001262)
HBM Healthcare Investments' Shareholders Approve Key Proposals
In the recent Shareholders' Meeting, HBM Healthcare Investments AG successfully gained approval for all board proposals. Hans Peter Hasler, Chairman, along with board members Dr. Rudolf Lanz, Mario G. Giuliani, Dr. Stella X. Xu, and Dr. Elaine V. Jones, have been re-elected for another year. Similarly, the Compensation Committee members remain unchanged
The shareholders consented to a capital reduction by cancelling 125,000 treasury shares from the 2025 buyback program. Additionally, a dividend of CHF 9.00 per share was ratified, set for payment on June 19, 2026. The ex-dividend date is June 17, 2026.
The presentation from the meeting is available on HBM's website. For inquiries, Dr. Andreas Wicki is the primary contact.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de HBM Healthcare Investments AG